Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology

Journal: Nature Biotechnology

Published: 2021-04-12

DOI: 10.1038/s41587-021-00857-z

Affiliations: 57

Authors: 86

Go to article
Institutions Share
National Center for Toxicological Research (NCTR), USFDA, United States of America (USA) 0.07
Roche Sequencing Solutions (RSS), United States of America (USA) 0.07
ResearchDx, Inc., United States of America (USA) 0.06
Cancer Genetics, Inc. (CGI), United States of America (USA) 0.06
Integrated DNA Technologies, Inc., United States of America (USA) 0.05
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.05
Burning Rock Biotech Ltd., China 0.05
ARUP Laboratories, Utah, United States of America (USA) 0.04
Garvan Institute of Medical Research, Australia 0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.03
Agilent Technologies, Inc., United States of America (USA) 0.03
Omniseq, Inc., United States of America (USA) 0.03
Thermo Fisher Scientific Inc., United States of America (USA) 0.03
Illumina, Inc., United States of America (USA) 0.02
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA) 0.02
NIHR Biomedical Research Centre for Cancer, United Kingdom (UK) 0.02
AstraZeneca United States, United States of America (USA) 0.02
Elim Biopharmaceuticals, Inc., United States of America (USA) 0.02
Massachusetts General Hospital (MGH), United States of America (USA) 0.02
Stanford University, United States of America (USA) 0.02
University of New South Wales (UNSW Sydney), Australia 0.02
NIH National Heart, Lung, and Blood Institute (NHLBI), United States of America (USA) 0.01
EATRIS ERIC- European Infrastructure for Translational Medicine, Netherlands 0.01
University of Arkansas for Medical Sciences (UAMS), United States of America (USA) 0.01
University of Arkansas at Little Rock (UALR), United States of America (USA) 0.01
East China Normal University (ECNU), China 0.01
University of Massachusetts Lowell (UMass Lowell), United States of America (USA) 0.01
Qiagen USA, United States of America (USA) 0.01
Accugenomics, Inc., United States of America (USA) 0.01
Liangpei gene Biotechnology (Wuhan) Co., Ltd., China 0.01
Cornell University, United States of America (USA) 0.01
NIH NIA Intramural Research Program (IRP), United States of America (USA) 0.01
NIH National Institute of Environmental Health Sciences (NIEHS), United States of America (USA) 0.01
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.01
Immuneering Corporation, United States of America (USA) 0.01
Q2 Solutions, United States of America (USA) 0.01
The University of Toledo (UT), United States of America (USA) 0.01
Institute for Molecular Medicine Finland (FIMM), Finland 0.01
The University of Utah (Utah), United States of America (USA) 0.01
Central European Institute of Technology (CEITEC), Czech Republic 0.01
Fudan University, China 0.01
The University of Queensland (UQ), Australia 0
State Key Laboratory of Genetic Engineering, Fudan University, China 0
Fudan University Shanghai Cancer Center (FUSCC), China 0

Return